维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="Hodsman"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Parathy- roid hormone and teriparatide for the treatment of osteopo- rosis: A review of the evidence and suggested guidelines for its use显示文摘	Hodsman A B Bauer D C Dempster D W	2005	Endocr Rev2005，26，5：	1
2	Angiotensin levels, hemodynamics and sympathoadrenal function after low-dose captopril in heart failure显示文摘	Cleland J Semple P Hodsman P	1984	Am J Med1984，77，5：	1
3	A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroidhormon and sequential calcitonin to improve bone mass inpostmenopausal women with osteoporosis显示文摘	Hodsman AB Fraher LJ Watson PH		0，，：	1
4	Parathyroid hormone and teriparatide for the treatment of osteoporosis : a review of the evidence and suggested guidelines for its use 显示文摘	Hodsman A B Bauer D C Dempster D W	2005	Endocr Rev2005，26，5：	1
5	Angiotensin Ⅱ levels,hemodynamics and sympatho-adrenal function after low dose captorpril in heart failure显示文摘	Semple P Hodsman P	1984	Am J Med1984，77，：	1
6	Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postmenopausal women with osteoporosis显示文摘	Neer RM Arnaud CD Zanchetta JR Prince R Gaich GA Reginster JY Hodsman AB Eriksen EF Ish-Shalom S Genant HK Wang O Mitlak BH		0，，：	1
7	Safety and efficacy of human parathyroid hormone (1 -34) in increasing bone mineral density in postmenopausal osteoporosis显示文摘	Hodsman AB Hanley DA Ettinger MP	2003	J Clin Endocrinol Metab2003，88，3：	1
8	10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program 显示文摘	Hodsman AB Leslie WD Tsang JF	2008	Arch Intern Med2008，168，：	1
9	Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis显示文摘	Neer RM Arnaud CD Zanchetta JR Prince R Gaich GA Reginster JY Hodsman AB Eriksen EF Ish-Shalom S Genant HK Wang O Mitlak BH		N Engl J Me0，，：	1
10	Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, andTreatment of CKD-Mineral and Bone Disorder (CKD-MBD)显示文摘	MANNS B J HODSMAN A ZIMMERMAN D L	2010	AmJ Kidney Dis2010，55，5：	1
11	Use of bisphosphonates in the treatment of osteoporosis显示文摘	Hodsman Anthony MD FRCPC	1996	Canadian Medical Association Journal1996，155，7：	1
12	A phase 1, randomi- zed, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics 显示文摘	Hodsman P Ashman C Cahn A et d	2012	BrJ Clin Pharmacol2012，75，1：	1
13	UK Renal Registry 11th Annual Report ( December 2008):chapter 7 survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses显示文摘	Ansell D Roderiek P Hodsman A	2009	Nephron Clin Pract2009，111，1：	1
14	Parathyroid hormone and teriparatide for the treatment of osteoporosis:a review of the evidence and suggested guidelines for its use显示文摘	Hodsman AB Bauer DC Dempster DW	2005	Endocr Rev2005，26，5：	1
15	A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis 显示文摘	Hodsman AB Fraher LJ Watson PH	1997	J Clin Endocrinol Metab1997，82，2：	1
16	Do bisphosphonates reduce the risk of osteoporotic fractures?An evaluation of the evidence to date显示文摘	Hodsman AB Hanley DA Josse R	2002	CMAJ2002，166，11：	1
17	UK Renal Registry 11th Annual Report(December 2008):Chapter 4 ESRD prevalent rates in 2007 in the UK:national and centre-specific analyses显示文摘	Farrington K Hodsman A Casula A	2009	Nephron Clin Pract2009，111，1：	1
18	Functional analysis of a type 1 parathyroid hormone receptor intracellular tail mutant : effects on second messenger generation and cellular targeting 显示文摘	Patterson EK Hodsman AB Hendy GN	2010	Bone2010，46，4：	1
19	Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin显示文摘	Hodsman AB Toogood JH Jennings B	1991	J Clin Endocrinol Metab1991，72，3：	1
20	Parathyroid hormone and teriparatide for the treatment of osteoporosis :a review of the evidence and suggested guidelines for its use 显示文摘	HODSMAN A B BAUER D C DEMPSTER D W	2005	Endocr Rev2005，26，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示